Nope, we have a long history to go by with this management crew. There are many companies with approved therapies that go belly up or remain a small boutique shop because of mismanagement, lack of urgency, limited to no institutional investor support, no big pharma interest, etc.
It wont be surprising if hedge funds and so called manipulators establish another major short position if there is a decent spike at the UK approval. It will be easy money for them again as they know that there will be no institutional or big pharma support anytime soon. TLD, JAMA, MIA, and Roswell Park announcements didn't attract any major institutional funds or big pharmas. So highly likely UK approval wont either. 2025 will be another lost year.
My bet on big pharma remains open. I know you refused earlier but I just extended the timeline from end of March 2025 to end of June 2025. In case you or your buddies want to participate and have enough confidence in LP et al.
Market Data 
Markets 
AI
